Non-Small Cell Lung Cancer Market Is Likely to Experience a Tremendous Growth by 2029

Non-Small Cell Lung Cancer Market is growing at a CAGR of 9.6% during the forecast period. NSCLC is a type of cancer that is most common among smokers as well as non-smokers group of people. NSCLC in comparison to the other form of cancer called small cell lung cancer grows and spreads less aggressively. Therefore, NSCLC has a better chance of treatment with surgery, chemotherapy, and other medical treatments. The major factor propelling the growth of the NSCLC market includes evolving drug landscape for the treatment of NSCLC. The major factors that are augmenting the growth of the market are the rise in air pollution, smoking cigarettes, pipes, or cigars, being in exposure to asbestos, arsenic, chromium, beryllium, nickel, soot, or tar in the workplace, and being exposed to radiation. Around 84% of the tumor is non-small cell lung cancer and most of the advanced stage is treated with chemotherapy, targeted drugs, and/or immunotherapy. 

In addition to this, hereditary causes and being infected with HIV are another factor that drives the global non-small cell lung cancer diagnostics and therapeutics market. However, the high cost of drugs and treatment and the risk associated with it are some of the restraints that can challenge the growth of the market in the forecast period. Conversely rise in better chances of treatment with surgery, chemotherapy, and other medical treatments are estimated to be the opportunity for the market players. Moreover, the significant increase in the R&D activities supported by government organizations such as the American Lung Association, which has made support for lung cancer research its top priority, is also aiding with the growth of the market. 

To Request a Sample of our Report on Non-Small Cell Lung Cancer Market:  https://www.omrglobal.com/request-sample/non-small-cell-lung-cancer-market

Non-Small Cell Lung Cancer Market Segmentation

By Type

Adenocarcinomas
Squamous Cell Carcinoma
Large Cell Carcinomas
Others

By Therapy

Chemotherapy
Targeted Therapy
Radiation Therapy
Surgery
Cryosurgery
Others

 By Diagnosis

CT Scan
X-Rays
Sputum Cytology
Bronchoscopy
Laboratory Tests
Thoracoscopy
Others

 By End-User

Multispeciality Hospitals
Cancer Research Centers

A full Report of Non-Small Cell Lung Cancer Market is Available @  https://www.omrglobal.com/industry-reports/non-small-cell-lung-cancer-market

Regional Analysis                                                                                                                                                                            

North America                                                                                                           

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America
Middle East and Africa 

Company Profiles

AbbVie Inc.
Agena Bioscience, Inc.
Arqule Inc.
Amgen Inc. 
AstraZeneca PLC
Bayer AG
Biodesix, Inc.
Boehringer Ingelheim International GmbH
Bristol Myers Squibb Co.
DAIICHI SANKYO CO. LTD.
Eli Lilly and Co. 
Exosome Diagnostics Corp.
Hoffman-La Roche, Inc.
Genentech, Inc. 
GlaxoSmithKline PLC
Illumina, Inc.
Merck & Co., Inc.
Novartis International Ag
Personal Genome Diagnostics Inc.
Pfizer Inc.
Qiagen NV
Sanofi SA
SAGA Diagnostics AB
Thermo Fisher Scientific Inc.

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/non-small-cell-lung-cancer-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.